Rational guide RNA engineering for small-molecule control of CRISPR/Cas9 and gene editing

Nucleic Acids Res. 2022 May 6;50(8):4769-4783. doi: 10.1093/nar/gkac255.

Abstract

It is important to control CRISPR/Cas9 when sufficient editing is obtained. In the current study, rational engineering of guide RNAs (gRNAs) is performed to develop small-molecule-responsive CRISPR/Cas9. For our purpose, the sequence of gRNAs are modified to introduce ligand binding sites based on the rational design of ligand-RNA pairs. Using short target sequences, we demonstrate that the engineered RNA provides an excellent scaffold for binding small molecule ligands. Although the 'stem-loop 1' variants of gRNA induced variable cleavage activity for different target sequences, all 'stem-loop 3' variants are well tolerated for CRISPR/Cas9. We further demonstrate that this specific ligand-RNA interaction can be utilized for functional control of CRISPR/Cas9 in vitro and in human cells. Moreover, chemogenetic control of gene editing in human cells transfected with all-in-one plasmids encoding Cas9 and designer gRNAs is demonstrated. The strategy may become a general approach for generating switchable RNA or DNA for controlling other biological processes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • CRISPR-Cas Systems / genetics
  • Gene Editing*
  • Humans
  • Ligands
  • Plasmids
  • RNA, Guide, CRISPR-Cas Systems* / genetics
  • RNA, Guide, CRISPR-Cas Systems* / metabolism

Substances

  • RNA, Guide, CRISPR-Cas Systems
  • Ligands